GRABM-L
GRABM-L. Means the Phase 2 clinical trial conducted by Geron entitled: "A Phase II, Multi-Center, Open-Label Study Evaluating the Efficacy and Safety of GRN1005 in Non-Small Cell Lung Cancer Patients with Brain Metastases," Protocol No. CP1005B017.
All Definitions
Found in
GERON CORP contract